Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Defining the Role of Physiotherapy in Palliative Care in Multiple Sclerosis.
BRIEF: Teva files for Copaxone-Laquinimod patent
Factors in Patient Empowerment: A Survey of an Online Patient Research Network.
Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
American Academy of Neurology Annual Meeting
New data reinforce efficacy of TECFIDERA® (dimethyl fumarate) in MS patients with high disease activity
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Episode 11 with Dr. Jack Antel on remyelination and on bedside-to-bench research
12th International Conference on Myasthenia Gravis and Related Disorders
Three-Month Test-Retest Reliability of Center of Pressure Motion During Standing Balance in Individuals with Multiple Sclerosis.
PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
World Congress of Neurology (WCN) 2015
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?
[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Reassessing the risk of natalizumab-associated PML.
Susceptibility tensor imaging (STI) of the brain.
FOCIS: Advanced Course in Basic & Clinical Immunology
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies.
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis.

Pages